From: Antithrombin use and 28-day in-hospital mortality among severe-burn patients: an observational nationwide study
Control
Antithrombin
Difference (95% CI)
P value
Unmatched groups
13.5% (415/3071)
39.5% (60/152)
−26.0% (−31.7 to −20.2)
<0.001
Propensity-matched groups
47.6% (49/103)
33.0% (34/103)
14.7% (1.2 to 28.0)
0.03